发明名称 |
Antagonists of activin-actriia and uses for increasing red blood cell levels |
摘要 |
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. |
申请公布号 |
US8895016(B2) |
申请公布日期 |
2014.11.25 |
申请号 |
US200912459188 |
申请日期 |
2009.06.26 |
申请人 |
Acceleron Pharma, Inc. |
发明人 |
Sherman Matthew L.;Seehra Jasbir;Borgstein Niels |
分类号 |
A61K39/00;A61K38/00;A61K38/17;C07K14/71;A61K38/22 |
主分类号 |
A61K39/00 |
代理机构 |
Ropes & Gray LLP |
代理人 |
Ropes & Gray LLP |
主权项 |
1. A method for treating anemia in a patient, the method comprising administering to a patient in need thereof an effective amount of an ActRIIa polypeptide selected from the group consisting of:
a) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 2; b) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 3; c) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 7; d) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 12; and e) a polypeptide comprising an amino acid sequence that is encoded by a nucleic acid that hybridizes to the complement of SEQ ID NO:5 in the presence of 6.0 sodium/sodium citrate (SSC) at 45° C. followed by a wash in 2.0 SSC at 45° C., andwherein the ActRIIa polypeptide binds to activin. |
地址 |
Cambridge MA US |